Outcomes of Regional Consensus Treatment Guidelines for Management of Surgery, Invasive Procedures and Control of Hemorrhages in Patients with Bleeding Disorders; and Management of Thrombosis and Thromboprophylaxis in Patients with Thrombophilia
Overview
Tab Title Description
Study type
InterventionalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 17-006970
Sponsor Protocol Number: 17-006970
About this study
The purpose of this study is to develop consensus guidelines and establish baseline outcomes data for various clinical complications and procedural events requiring treatment in the population of patients.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- The subject population includes all patients with the underlying hemostatic disorder and clinical indication for one of the procedures/bleeding/thrombotic events for which guidelines have been developed and defined.
- After the patient/guardian has had the study explained to them, had their questions answered and signed a written informed consent, they will be treated as defined by the guidelines and have demographic and outcomes data collected for analysis.
Exclusion Criteria:
- Patient must have a congenital bleeding or clotting disorder.
- No patients will be excluded based on gender, ethnicity or age.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Rajiv Pruthi, M.B.B.S. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available